WU:NYSEWestern Union Company (The) Analysis
Data as of 2026-05-11 - not real-time
$9.07
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Western Union’s stock is trading around $9.07, just below its 20‑day and 50‑day SMAs and marginally above the 200‑day SMA, indicating a neutral price stance. The RSI sits near 48, reinforcing a lack of clear momentum, while a bearish MACD histogram and decreasing volume suggest short‑term pressure. Volatility is elevated at over 30% for the past month, yet the beta of roughly 0.6 points to modest systematic risk, and the market sentiment index is in the “Extreme Greed” zone, hinting at potential over‑optimism.
Fundamentally, the company’s PE of ~6.7 is well below the industry average of ~16.4, but the DCF‑derived fair value of $6.9 is significantly under the current price, creating a valuation tension. Recent earnings missed expectations, profit margins slipped, and debt levels are extreme (debt‑to‑equity > 280), though cash flow covers the roughly 10% dividend payout, which remains attractive. Analysts rate the stock “underperform,” and price targets cluster around $9‑9.5, offering limited upside despite the high yield.
Fundamentally, the company’s PE of ~6.7 is well below the industry average of ~16.4, but the DCF‑derived fair value of $6.9 is significantly under the current price, creating a valuation tension. Recent earnings missed expectations, profit margins slipped, and debt levels are extreme (debt‑to‑equity > 280), though cash flow covers the roughly 10% dividend payout, which remains attractive. Analysts rate the stock “underperform,” and price targets cluster around $9‑9.5, offering limited upside despite the high yield.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Recent earnings miss and profit decline
- Bearish MACD and decreasing volume
- Price hovering near short‑term support
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Attractive dividend yield above 10%
- Valuation gap between low PE and DCF fair value
- High leverage requiring monitoring
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Sustained cash flow covering dividend payouts
- Strong ROE indicating efficient capital use
- Potential for share buybacks to improve EPS
Key Metrics & Analysis
Financial Health
Revenue Growth-0.10%
Profit Margin10.88%
P/E Ratio6.7
ROE47.66%
ROA5.43%
Debt/Equity288.12
P/B Ratio3.0
Op. Cash Flow$504.5M
Free Cash Flow$290.7M
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI47.9
Support$7.95
Resistance$9.64
MA 20$9.20
MA 50$9.21
MA 200$8.94
MACDBearish
VolumeDecreasing
Fear & Greed Index90.73
Valuation
Fair Value$6.90
Target Price$9.46
Upside/Downside4.32%
GradeFair
TypeValue
Dividend Yield10.36%
Risk Assessment
Beta0.61
Volatility32.76%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.